US Health Secretary Robert F Kennedy Jr. has released plans that would let compounding pharmacies prepare six popular peptides that the FDA has not approved. The draft came from the health secretary’s office rather than the FDA, which the report calls an unusual move, and a two week public comment period will follow once it is officially published. Experts have warned that these injectable peptides lack clinical trials for humans and have unknown long term effects. Do you think access should be loosened?

#RFKJr #Peptides #FDA #HealthNews #USNews